Request Sample Inquiry
Radiopharmaceuticals Market

Radiopharmaceuticals Market

Radiopharmaceuticals Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

148

Base Year:

2022

Date

May - 2023

Format:

PDF XLS PPT

Report Code:

VMR-2143

Segments Covered
  • By Type By Type Diagnostic Nuclear Medicine, SPECT Radiopharmaceuticals, Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other, PET Radiopharmaceuticals, F-18, RU-82, Others, Therapeutic Nuclear Medicine, Alpha Emitters, Ra-223, Brachytherapy Isotopes, Intoiodine-125, Palladium-103, Cesium-131, Iridium-192, Other brachytherapy isotopes, Beta Emitters, Intoiodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other beta emitters
  • By Application By Application Diagnostic Applications, SPECT Applications, Cardiology, Bone Scans, Thyroid Applications, Pulmonary Scans, Other SPECT Applications, PET applications, Oncology, Cardiology, Neurology, Other PET applications, Therapeutic Applications, Thyroid Indications, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Indications
  • By Procedural Volume Assessment By Procedural Volume Assessment Diagnostic Procedures, Therapeutic Procedures, Source
  • By Source By Source Nuclear Reactors, Cyclotrons
  • By End User By End User Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes, Others
  • By Region By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 5.2 Billion
Revenue 2030Revenue 2030: USD 9.75 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 9.4%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Radiopharmaceuticals Market Segment Analysis

  • Radiopharmaceuticals Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Diagnostic Nuclear Medicine
    • SPECT Radiopharmaceuticals
    • Technetium-99m
    • Thallium-201
    • Gallium-67
    • Iodine-123
    • Other
    • PET Radiopharmaceuticals
    • F-18
    • RU-82
    • Others
    • Therapeutic Nuclear Medicine
    • Alpha Emitters
    • Ra-223
    • Brachytherapy Isotopes
    • Intoiodine-125
    • Palladium-103
    • Cesium-131
    • Iridium-192
    • Other brachytherapy isotopes
    • Beta Emitters
    • Intoiodine-131
    • Yttrium-90
    • Samarium-153
    • Lutetium-177
    • Rhenium-186
    • Other beta emitters
  • Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2018 - 2030)
    • Diagnostic Applications
    • SPECT Applications
    • Cardiology
    • Bone Scans
    • Thyroid Applications
    • Pulmonary Scans
    • Other SPECT Applications
    • PET applications
    • Oncology
    • Cardiology
    • Neurology
    • Other PET applications
    • Therapeutic Applications
    • Thyroid Indications
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Indications
  • Radiopharmaceuticals Procedural Volume Assessment Outlook (Revenue, USD Million, 2018 - 2030)
    • Diagnostic Procedures
    • Therapeutic Procedures
    • Source
  • Radiopharmaceuticals Source Outlook (Revenue, USD Million, 2018 - 2030)
    • Nuclear Reactors
    • Cyclotrons
  • Radiopharmaceuticals End User Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospitals
    • Ambulatory Surgical Centers
    • Diagnostic Centers
    • Cancer Research Institutes
    • Others
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Radiopharmaceuticals Market, by Type
        • Diagnostic Nuclear Medicine
        • SPECT Radiopharmaceuticals
        • Technetium-99m
        • Thallium-201
        • Gallium-67
        • Iodine-123
        • Other
        • PET Radiopharmaceuticals
        • F-18
        • RU-82
        • Others
        • Therapeutic Nuclear Medicine
        • Alpha Emitters
        • Ra-223
        • Brachytherapy Isotopes
        • Intoiodine-125
        • Palladium-103
        • Cesium-131
        • Iridium-192
        • Other brachytherapy isotopes
        • Beta Emitters
        • Intoiodine-131
        • Yttrium-90
        • Samarium-153
        • Lutetium-177
        • Rhenium-186
        • Other beta emitters
      • North America Radiopharmaceuticals Market, by Application
        • Diagnostic Applications
        • SPECT Applications
        • Cardiology
        • Bone Scans
        • Thyroid Applications
        • Pulmonary Scans
        • Other SPECT Applications
        • PET applications
        • Oncology
        • Cardiology
        • Neurology
        • Other PET applications
        • Therapeutic Applications
        • Thyroid Indications
        • Bone Metastasis
        • Lymphoma
        • Endocrine Tumors
        • Other Indications
      • North America Radiopharmaceuticals Market, by Procedural Volume Assessment
        • Diagnostic Procedures
        • Therapeutic Procedures
        • Source
      • North America Radiopharmaceuticals Market, by Source
        • Nuclear Reactors
        • Cyclotrons
      • North America Radiopharmaceuticals Market, by End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
        • Cancer Research Institutes
        • Others
      • U.S.
        • U.S. Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • U.S. Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • U.S. Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • U.S. Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • U.S. Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Canada
        • Canada Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Canada Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Canada Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Canada Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Canada Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Mexico
        • Mexico Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Mexico Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Mexico Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Mexico Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Mexico Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
    • Europe
      • Europe Radiopharmaceuticals Market, by Type
        • Diagnostic Nuclear Medicine
        • SPECT Radiopharmaceuticals
        • Technetium-99m
        • Thallium-201
        • Gallium-67
        • Iodine-123
        • Other
        • PET Radiopharmaceuticals
        • F-18
        • RU-82
        • Others
        • Therapeutic Nuclear Medicine
        • Alpha Emitters
        • Ra-223
        • Brachytherapy Isotopes
        • Intoiodine-125
        • Palladium-103
        • Cesium-131
        • Iridium-192
        • Other brachytherapy isotopes
        • Beta Emitters
        • Intoiodine-131
        • Yttrium-90
        • Samarium-153
        • Lutetium-177
        • Rhenium-186
        • Other beta emitters
      • Europe Radiopharmaceuticals Market, by Application
        • Diagnostic Applications
        • SPECT Applications
        • Cardiology
        • Bone Scans
        • Thyroid Applications
        • Pulmonary Scans
        • Other SPECT Applications
        • PET applications
        • Oncology
        • Cardiology
        • Neurology
        • Other PET applications
        • Therapeutic Applications
        • Thyroid Indications
        • Bone Metastasis
        • Lymphoma
        • Endocrine Tumors
        • Other Indications
      • Europe Radiopharmaceuticals Market, by Procedural Volume Assessment
        • Diagnostic Procedures
        • Therapeutic Procedures
        • Source
      • Europe Radiopharmaceuticals Market, by Source
        • Nuclear Reactors
        • Cyclotrons
      • Europe Radiopharmaceuticals Market, by End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
        • Cancer Research Institutes
        • Others
      • U. K.
        • U.K. Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • U.K. Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • U.K. Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • U.K. Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • U.K. Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • France
        • France Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • France Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • France Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • France Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • France Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Germany
        • Germany Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Germany Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Germany Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Germany Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Germany Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Italy
        • Italy Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Italy Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Italy Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Italy Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Italy Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Spain
        • Spain Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Spain Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Spain Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Spain Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Spain Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Rest of Europe
        • Rest of Europe Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Rest of Europe Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Rest of Europe Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Rest of Europe Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Rest of Europe Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
    • Asia Pacific
      • Asia Pacific Radiopharmaceuticals Market, by Type
        • Diagnostic Nuclear Medicine
        • SPECT Radiopharmaceuticals
        • Technetium-99m
        • Thallium-201
        • Gallium-67
        • Iodine-123
        • Other
        • PET Radiopharmaceuticals
        • F-18
        • RU-82
        • Others
        • Therapeutic Nuclear Medicine
        • Alpha Emitters
        • Ra-223
        • Brachytherapy Isotopes
        • Intoiodine-125
        • Palladium-103
        • Cesium-131
        • Iridium-192
        • Other brachytherapy isotopes
        • Beta Emitters
        • Intoiodine-131
        • Yttrium-90
        • Samarium-153
        • Lutetium-177
        • Rhenium-186
        • Other beta emitters
      • Asia Pacific Radiopharmaceuticals Market, by Application
        • Diagnostic Applications
        • SPECT Applications
        • Cardiology
        • Bone Scans
        • Thyroid Applications
        • Pulmonary Scans
        • Other SPECT Applications
        • PET applications
        • Oncology
        • Cardiology
        • Neurology
        • Other PET applications
        • Therapeutic Applications
        • Thyroid Indications
        • Bone Metastasis
        • Lymphoma
        • Endocrine Tumors
        • Other Indications
      • Asia Pacific Radiopharmaceuticals Market, by Procedural Volume Assessment
        • Diagnostic Procedures
        • Therapeutic Procedures
        • Source
      • Asia Pacific Radiopharmaceuticals Market, by Source
        • Nuclear Reactors
        • Cyclotrons
      • Asia Pacific Radiopharmaceuticals Market, by End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
        • Cancer Research Institutes
        • Others
      • China
        • China Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • China Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • China Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • China Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • China Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Japan
        • Japan Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Japan Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Japan Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Japan Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Japan Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Germany
        • Germany Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Germany Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Germany Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Germany Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Germany Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • India
        • India Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • India Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • India Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • India Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • India Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • South Korea
        • South Korea Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • South Korea Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • South Korea Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • South Korea Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • South Korea Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • South East Asia
        • South East Asia Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • South East Asia Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • South East Asia Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • South East Asia Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • South East Asia Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Rest of Asia Pacific
        • Rest of Asia Pacific Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Rest of Asia Pacific Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Rest of Asia Pacific Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Rest of Asia Pacific Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Rest of Asia Pacific Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
    • Latin America
      • Latin America Radiopharmaceuticals Market, by Type
        • Diagnostic Nuclear Medicine
        • SPECT Radiopharmaceuticals
        • Technetium-99m
        • Thallium-201
        • Gallium-67
        • Iodine-123
        • Other
        • PET Radiopharmaceuticals
        • F-18
        • RU-82
        • Others
        • Therapeutic Nuclear Medicine
        • Alpha Emitters
        • Ra-223
        • Brachytherapy Isotopes
        • Intoiodine-125
        • Palladium-103
        • Cesium-131
        • Iridium-192
        • Other brachytherapy isotopes
        • Beta Emitters
        • Intoiodine-131
        • Yttrium-90
        • Samarium-153
        • Lutetium-177
        • Rhenium-186
        • Other beta emitters
      • Latin America Radiopharmaceuticals Market, by Application
        • Diagnostic Applications
        • SPECT Applications
        • Cardiology
        • Bone Scans
        • Thyroid Applications
        • Pulmonary Scans
        • Other SPECT Applications
        • PET applications
        • Oncology
        • Cardiology
        • Neurology
        • Other PET applications
        • Therapeutic Applications
        • Thyroid Indications
        • Bone Metastasis
        • Lymphoma
        • Endocrine Tumors
        • Other Indications
      • Latin America Radiopharmaceuticals Market, by Procedural Volume Assessment
        • Diagnostic Procedures
        • Therapeutic Procedures
        • Source
      • Latin America Radiopharmaceuticals Market, by Source
        • Nuclear Reactors
        • Cyclotrons
      • Latin America Radiopharmaceuticals Market, by End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
        • Cancer Research Institutes
        • Others
      • Brazil
        • Brazil Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Brazil Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Brazil Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Brazil Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Brazil Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Argentina
        • Argentina Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Argentina Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Argentina Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Argentina Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Argentina Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Rest of Latin America
        • Rest of Latin America Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Rest of Latin America Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Rest of Latin America Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Rest of Latin America Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Rest of Latin America Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
    • Middle East & Africa
      • Middle East & Africa Radiopharmaceuticals Market, by Type
        • Diagnostic Nuclear Medicine
        • SPECT Radiopharmaceuticals
        • Technetium-99m
        • Thallium-201
        • Gallium-67
        • Iodine-123
        • Other
        • PET Radiopharmaceuticals
        • F-18
        • RU-82
        • Others
        • Therapeutic Nuclear Medicine
        • Alpha Emitters
        • Ra-223
        • Brachytherapy Isotopes
        • Intoiodine-125
        • Palladium-103
        • Cesium-131
        • Iridium-192
        • Other brachytherapy isotopes
        • Beta Emitters
        • Intoiodine-131
        • Yttrium-90
        • Samarium-153
        • Lutetium-177
        • Rhenium-186
        • Other beta emitters
      • Middle East & Africa Radiopharmaceuticals Market, by Application
        • Diagnostic Applications
        • SPECT Applications
        • Cardiology
        • Bone Scans
        • Thyroid Applications
        • Pulmonary Scans
        • Other SPECT Applications
        • PET applications
        • Oncology
        • Cardiology
        • Neurology
        • Other PET applications
        • Therapeutic Applications
        • Thyroid Indications
        • Bone Metastasis
        • Lymphoma
        • Endocrine Tumors
        • Other Indications
      • Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
        • Diagnostic Procedures
        • Therapeutic Procedures
        • Source
      • Middle East & Africa Radiopharmaceuticals Market, by Source
        • Nuclear Reactors
        • Cyclotrons
      • Middle East & Africa Radiopharmaceuticals Market, by End User
        • Hospitals
        • Ambulatory Surgical Centers
        • Diagnostic Centers
        • Cancer Research Institutes
        • Others
      • GCC Countries
        • GCC Countries Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • GCC Countries Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • GCC Countries Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • GCC Countries Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • GCC Countries Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • South Africa
        • South Africa Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • South Africa Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • South Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • South Africa Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • South Africa Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Radiopharmaceuticals Market, by Type
          • Diagnostic Nuclear Medicine
          • SPECT Radiopharmaceuticals
          • Technetium-99m
          • Thallium-201
          • Gallium-67
          • Iodine-123
          • Other
          • PET Radiopharmaceuticals
          • F-18
          • RU-82
          • Others
          • Therapeutic Nuclear Medicine
          • Alpha Emitters
          • Ra-223
          • Brachytherapy Isotopes
          • Intoiodine-125
          • Palladium-103
          • Cesium-131
          • Iridium-192
          • Other brachytherapy isotopes
          • Beta Emitters
          • Intoiodine-131
          • Yttrium-90
          • Samarium-153
          • Lutetium-177
          • Rhenium-186
          • Other beta emitters
        • Rest of Middle East & Africa Radiopharmaceuticals Market, by Application
          • Diagnostic Applications
          • SPECT Applications
          • Cardiology
          • Bone Scans
          • Thyroid Applications
          • Pulmonary Scans
          • Other SPECT Applications
          • PET applications
          • Oncology
          • Cardiology
          • Neurology
          • Other PET applications
          • Therapeutic Applications
          • Thyroid Indications
          • Bone Metastasis
          • Lymphoma
          • Endocrine Tumors
          • Other Indications
        • Rest of Middle East & Africa Radiopharmaceuticals Market, by Procedural Volume Assessment
          • Diagnostic Procedures
          • Therapeutic Procedures
          • Source
        • Rest of Middle East & Africa Radiopharmaceuticals Market, by Source
          • Nuclear Reactors
          • Cyclotrons
        • Rest of Middle East & Africa Radiopharmaceuticals Market, by End User
          • Hospitals
          • Ambulatory Surgical Centers
          • Diagnostic Centers
          • Cancer Research Institutes
          • Others
FAQ
Frequently Asked Question
  • The global Radiopharmaceuticals valued at USD 5.2 Billion in 2022 and is expected to reach USD 9.75 Billion in 2030 growing at a CAGR of 9.4%.

  • The prominent players in the market are Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), Bracco Imaging (Italy), Nordion (Canada), Advanced Accelerator Applications (France), NTP Radioisotopes (South Africa), NorthStar Medical Radioisotopes (U.S.), Eckert & Ziegler (Germany), Braun Melsungen AG (Germany), Smith+Nephew (Germany), Zimmer Biomet (U.S.), Hanger Inc. (U.S.) and Otto Bock Healthcare GmBH (Germany).

  • The market is project to grow at a CAGR of 9.4% between 2023 and 2030.

  • The driving factors of the Radiopharmaceuticals include

    • Increasing Cases of Cancer and Heart Diseases

  • North America was the leading regional segment of the Radiopharmaceuticals in 2022.